Candidate view
Launch economics: a new lung treatment in Germany
The prompt
A fictional mid-sized pharma company plans to launch a new treatment for a chronic lung disease in Germany. About 50,000 patients are eligible, and it expects to treat 20 percent of them at peak. The net price (after discounts) is EUR 12,000 per patient per year. Making the drug costs 10 percent of net sales, and the medical and sales team costs EUR 30 million a year. What are peak sales and peak yearly contribution after the sales team?
Your interviewer will share data as you ask for it. Ask clarifying questions, state a hypothesis, then lay out your structure out loud before you calculate.
Case timer
00:00
Notes stay on this page only. They are not saved and are gone when you leave or reload.
Finished the case and heard your feedback? Mark it done so it counts in your progress on this device.